Testing the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial Cancers
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Xencor, Inc.
Atavistik Bio, Inc
Compass Therapeutics
Eli Lilly and Company
Whitehawk Therapeutics, Inc.
NiKang Therapeutics, Inc.
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Kivu Bioscience Inc.
AstraZeneca
Alterome Therapeutics, Inc.
Boehringer Ingelheim
Eli Lilly and Company
BeOne Medicines
Whitehawk Therapeutics, Inc.
Eli Lilly and Company
University of Miami
Accent Therapeutics
Seagen Inc.
AbbVie
Context Therapeutics Inc.
Myeloid Therapeutics
Tizona Therapeutics, Inc
SEED Therapeutics, Inc.
Dana-Farber Cancer Institute
TORL Biotherapeutics, LLC
Normunity AccelCo, Inc.
BioNTech SE
NiKang Therapeutics, Inc.
USWM, LLC (dba US WorldMeds)
IDEAYA Biosciences
MacroGenics
Mayo Clinic
Cogent Biosciences, Inc.
UNC Lineberger Comprehensive Cancer Center
SystImmune Inc.
Pheon Therapeutics
Solve Therapeutics
MOMA Therapeutics
Tongji Hospital
Doma Biopharmaceutical(Suzhou)Co., Ltd.
M.D. Anderson Cancer Center
Eli Lilly and Company
Shanghai Best-Link Bioscience, LLC
Seagen Inc.
Fusion Pharmaceuticals Inc.